The incidence of symptomatic upper limb venous thrombosis associated with midline catheter: Prospective observation

2018 ◽  
Vol 19 (5) ◽  
pp. 492-495 ◽  
Author(s):  
Katerina Lisova ◽  
Jaroslava Hromadkova ◽  
Katerina Pavelková ◽  
Vladimir Zauška ◽  
Jan Havlin ◽  
...  
Keyword(s):  
Venous Thrombosis ◽  
Median Time ◽  
Upper Limb ◽  
Venous Access ◽  
Cephalic Vein ◽  
Sonographic Examination ◽  
Hospitalised Patients

Aim: The evaluation of the incidence of symptomatic upper limb venous thrombosis (ULVT) associated with midline catheters in patients admitted to the hospital. Methods: The frequency of symptomatic ULVT diagnosed in a group of patients with midline catheters confirmed by sonographic examination in hospitalised patients at Faculty Hospital over the period of 1 year. Results: Four hundred thirty-nine midline catheters were inserted in 430 patients (250 women and 180 men) during year 2015. Nine patients had two midline catheters. The average age of the patient was 68 years (range: 19–96 years). The median time of midline catheter introduction into a vein was 10 days (range: 1–112 days). Symptomatic thrombosis was diagnosed in 20 patients (4.5%), 3.3/1000 catheter days. It was associated with gender (male) and midline insertion in the cephalic vein. Conclusion: The risk of upper limb symptomatic thrombosis associated with midline catheters during a stay in the hospital should be taken into consideration when indicating optimal venous access.

Are we managing deep venous thrombosis of the upper limb appropriately?

2004 ◽  
Vol 19 (3) ◽  
pp. 120-122
Author(s):  
N Fassiadis ◽  
L Pepas ◽  
M Chan ◽  
D Mason ◽  
M Morgan
Keyword(s):  
Risk Factors ◽  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Upper Limb ◽  
Malignant Disease ◽  
Central Venous Access ◽  
Venous Access ◽  
Primary Group ◽  
District Hospitals ◽  
Common Risk Factors

Objective: The objective of this retrospective study was to analyse risk factors, management and outcome of upper limb deep venous thrombosis (ULDVT) in two London district hospitals. Methods: The study group audited between May 1995 and July 2002 comprised 33 patients with ULDVTs, of which 12 were primary and 21 were secondary. Results: Common risk factors included malignant disease ( n=17, 51.5%), smoking ( n=16, 48.5%), central venous access ( n=9, 27.3%), cardiac disease ( n =6, 18.2%) and hormonal therapy ( n=4, 12.1%). None of the patients were evaluated for thoracic outlet compression. A thrombophilia screen was performed in eight patients with primary ULDVT and in seven patients with secondary ULDVT. Thrombophilic states were identified only in the primary group, in two patients. Twenty-eight patients were anticoagulated (84.8%) and overall symptoms resolved in 20 patients (60.6%). All 13 deaths occurred within the secondary group. Conclusions: The present study reveals that there is no consensus in investigating and managing patients with ULDVT, which is probably due to the variety of aetiological factors of this condition.

scholarly journals Evaluation of totally implantable catheters in healthy horses

2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Adriana Fernandes de Souza Garcia ◽  
Gesiane Ribeiro ◽  
Julia de Assis Arantes ◽  
Gustavo Morandini Reginato ◽  
Nathalia Villaca Xavier ◽  
...  
Keyword(s):  
Venous Thrombosis ◽  
Venous Access ◽  
Cephalic Vein ◽  
Implantation Technique ◽  
Limb Perfusion ◽  
High Incidence ◽  
Physical Examinations ◽  
Technical Effort ◽  
Post Implantation

Abstract Background For horses requiring prolonged daily cephalic intravenous regional limb perfusion (IVRLP), the use of a totally implantable catheter (TIC) could be indicated to reduce complications associated with frequent venipuncture or external catheterization. This study aims to evaluate the implantation technique of the TIC in the cephalic vein of horses for IVRLP, describe the complications associated with the device’s placement and use, and assess its viability up to 60 days after implantation. Totally implantable catheters, cut to 15 cm (n = 5) and 46 cm (n = 5) in length, were implanted into one cephalic vein in ten adult horses (n = 10). Twenty-four hours following placement, IVRLP with contrast was performed via the TIC and evaluated with radiography. Physical examinations, lameness evaluation, hematologic assessment, and the catheter patency tests were performed at scheduled intervals for the duration of catheterization (7–60 days). Results Catheters were implanted without difficulty and allowed for IVRLP 24 h post implantation. Complications resulted in removal of the catheters, with four maintained for 7 days, three in place for 15 days, and three catheters maintained for 60 days. Complications included lameness, limb swelling, catheter kinking, and venous thrombosis. Conclusions The implantation technique of the TIC in the cephalic vein of horses is feasible and requires minimal technical effort. Although TIC allows venous access without the need for repeated venipuncture, its long-term use presents complications. For horses requiring prolonged daily cephalic IVRLP, the use of a TIC could be indicated. However, the high incidence of venous thrombosis may limit clinical application.

An ultrasound-based technique in the management of totally implantable venous access devices with persistent withdrawal occlusion

2021 ◽  
pp. 112972982110232
Author(s):  
Sonia D’Arrigo ◽  
Maria Giuseppina Annetta ◽  
Mauro Pittiruti
Keyword(s):  
Venous Thrombosis ◽  
Real Time ◽  
Venous Access ◽  
Central Venous ◽  
Safe Method ◽  
Central Venous Port ◽  
Catheter Malfunction ◽  
Bubble Test ◽  
Current Guidelines ◽  
Venous Access Devices

Persistent withdrawal occlusion is a specific catheter malfunction characterized by inability to withdraw blood through the device while infusion is maintained. The main causes are fibroblastic sleeve and tip malposition (associated or not to venous thrombosis around the tip). All current guidelines recommend infusing vesicant/antiblastic drugs through a central venous port only after assessment of blood return. In PWO, blood return is impossible. We have recently started to assess the intravascular position of the tip and the delivery of the infusion in the proximity of the cavo-atrial junction utilizing transthoracic/subxiphoid ultrasound with the ‘bubble test’. We found that this is an easy, real-time, accurate and safe method for verifying the possibility of using a port for chemotherapy even in the absence of blood return, as it occurs with persistent withdrawal occlusion.

Major venous thrombosis in patients with indwelling venous access catheters

1986 ◽  
Vol 144 (11) ◽  
pp. 601-603 ◽  
Author(s):  
Phillip D. Strieker ◽  
Arumugam Manoharan ◽  
Kevin C. Hanel
Keyword(s):  
Venous Thrombosis ◽  
Venous Access

scholarly journals Outcome of cephalic vein cut-down approach: A safe and feasible approach for totally implantable venous access device placement

2010 ◽  
Vol 1 (6) ◽  
pp. 1029-1031 ◽  
Author(s):  
SHINICHIRO KOKETSU ◽  
SHINISHI SAMESIMA ◽  
SATOMI YONEYAMA ◽  
TOSHIYUKI OKADA ◽  
SHIGERU TOMOZAWA ◽  
...  
Keyword(s):  
Venous Access ◽  
Cephalic Vein ◽  
Access Device ◽  
Device Placement ◽  
Venous Access Device

scholarly journals Characteristics of Symptomatic Axillary Vein Thrombosis After Placement of Totally Implanted Venous Access Port in Cancer Patients

2020 ◽  
Vol 17 (3) ◽  
Author(s):  
Myung Gyu Song ◽  
Tae-Seok Seo ◽  
Woo Jin Yang
Keyword(s):  
Lung Cancer ◽  
Pancreatic Cancer ◽  
Venous Thrombosis ◽  
Cancer Patients ◽  
Venous Access ◽  
Axillary Vein ◽  
Access Port ◽  
Vein Thrombosis ◽  
Axillary Vein Thrombosis ◽  
Venous Access Port

Background: The incidence of venous thrombosis based on access route after implantation of the totally implanted venous access port (TIVAP) is controversial. Symptomatic TIVAP-related venous thrombosis remains relatively rare. However, characteristics of symptomatic axillary vein thrombosis after TIVAP implantation via access of the axillary vein has not been reported. Objectives: In this historical cohort study, the incidence and characteristics of venous thrombosis associated with TIVAP via the axillary vein in cancer patients were evaluated. Patients and Methods: A total of 4,773 TIVAPs were placed via the axillary vein in patients with various types of cancer between May 2012 and July 2018. Eighteen patients experienced symptomatic venous thrombosis associated with TIVAPs. Radiologic findings for venous thrombosis were evaluated using computed tomography (CT) including scans of the axillary vein. Medical records were retrospectively reviewed. Results: The prevalence of symptomatic thrombosis was 0.38% (18/4,773). The patients with symptomatic venous thrombosis included 14 males and four females. Among the 18 patients, the most common types of cancer were lung cancer (n = 7) and pancreatic cancer (n = 4), with the incidence rates of 0.79% (lung cancer, 7/882) and 1.58% (pancreatic cancer, 4/253), respectively. The median time between placement of the TIVAP and diagnosis of thrombosis was 35.5 days (range: 6 - 292 days). All symptomatic patients had thrombosis in the axillary vein on CT images. Symptoms were improved in all patients with treatment including removal of TIVAP at the time of diagnosis and following anticoagulation therapy. From the multiple binary logistic regression, pancreatic cancer and lung cancer were statistically significant risk factors of symptomatic axillary vein thrombosis. Conclusion: After insertion of TIVAPs through the axillary vein, symptomatic axillary vein thrombosis rarely developed. Pancreatic cancer and lung cancer were associated with the risk of symptomatic axillary vein thrombosis.

scholarly journals Cephalic vein approach for the implantable central venous access

Medicine ◽  
2019 ◽  
Vol 98 (46) ◽  
pp. e18007
Author(s):  
Jiyoung Rhu ◽  
Kang Woong Jun ◽  
Byung Joo Song ◽  
Kiyoung Sung ◽  
Jinbeom Cho
Keyword(s):  
Central Venous Access ◽  
Venous Access ◽  
Cephalic Vein ◽  
Central Venous

scholarly journals Comparison of Complication Rates of Implantable Venous Access Devices: Percutaneous Versus Cephalic Vein Cut-down Techniques

2013 ◽  
Vol 57 (5) ◽  
pp. 62S
Author(s):  
Farah Karipineni ◽  
Nadia Awad ◽  
Lisa Jablon ◽  
Nyali Taylor ◽  
Rashad G. Choudry
Keyword(s):  
Venous Access ◽  
Cephalic Vein ◽  
Complication Rates ◽  
Venous Access Devices

Chronic Venous Insufficiency of the Upper Limb Due to Outflow Obstruction of Venous Access

1988 ◽  
Vol 3 (4) ◽  
pp. 265-270
Author(s):  
A. Halevy ◽  
A. Zelikovski ◽  
D. Modai ◽  
Y. Swissgarten ◽  
R. Orda
Keyword(s):  
Upper Limb ◽  
Chronic Venous Insufficiency ◽  
Venous Insufficiency ◽  
Clinical Signs ◽  
Venous Access ◽  
Lower Limbs ◽  
Vein Thrombosis ◽  
Short Period ◽  
Cubital Fossa ◽  
Deep Vein

Two patients with angio-access for haemodialysis in whom the main venous outflow tract was thrombosed, developed severe chronic venous insufficiency (CVI) of the upper limb after a short period; one case developing a stasis ulcer of the cubital fossa. The angio-accesses were still functioning when the diagnosis was made. Treatment by surgery resulted in a dramatic regression of clinical signs of chronic venous insufficiency. CVI of the upper limb has not previously been described. CVI is a frequent and known complication after deep vein thrombosis (DVT) of the lower limbs, but never appears after DVT of the upper limbs. We describe two cases of upper limb CVI which developed as a complication of angio-access for haemodialysis treatment, and their successful treatment by surgery.

Safety and feasibility of upper limb vascular access for cardiac catheterization in anticoagulated and non-anticoagulated patients

2020 ◽  
pp. 112972982097152
Author(s):  
Felipe Pereira Lima Marques ◽  
Felipe Homem Valle ◽  
Gustavo Neves de Araujo ◽  
Guilherme Pinheiro Machado ◽  
Rodrigo Amantea ◽  
...  
Keyword(s):  
Upper Limb ◽  
Primary Outcome ◽  
Vascular Complications ◽  
Venous Access ◽  
Right Heart Catheterization ◽  
Heart Catheterization ◽  
Ultrasound Guided ◽  
Right Heart ◽  
Left And Right ◽  
Anticoagulated Patients

Background: The upper limb approach utilizing transradial access for combined left and right heart catheterization (CLRHC) and ultrasound-guided antecubital venous access for isolated right heart catheterization (IRHC) are strategies that may reduce risks, especially in anticoagulated patients. combined left and right heart catheterization Objectives: To assess safety and feasibility of upper limb approach for IRHC or CLRHC in anticoagulated versus non-anticoagulated patients. Methods: Ninety-three patients who underwent IRHC or CLRHC with ultrasound-guided antecubital venous access and transradial arterial access were prospectively enrolled. The primary outcome was a composite of procedure failure and incidence of immediate vascular complications. Results: Of the 93 patients, 44 (47%) were on anticoagulation and 49 (53%) were not. Mean age was 54 ± 17 and 53 ± 15 years, respectively. Atrial fibrillation (39% vs 15%) and chronic kidney disease (21% vs 6%) were more common in anticoagulated patients. The main indication for anticoagulation was deep vein thrombosis/pulmonary thromboembolism in 22 patients (50%). The primary outcome occurred in 4 (8%) patients in the non-anticoagulated group as compared with 0 in the anticoagulated group ( p = 0.12). Procedure failure occurred in two patients (4%) and immediate vascular complications in two patients (4%) in the non-anticoagulated group ( p = 0.3 for all). There was no difference between groups regarding duration of the procedure, radiation dose, fluoroscopy time, post-procedure recovery room time and median time to venous or arterial hemostasis. Conclusions: The upper limb approach for heart catheterization had similar rates of procedure failure and immediate vascular complications in anticoagulated patients when compared to non-anticoagulated patients.

Sign in / Sign up

Export Citation Format

Share Document